Preparation and biological evaluation of 99mTc-HYNIC-(Ser)3-D4 peptide for targeting and imaging of non-small-cell lung cancer

被引:15
作者
Zahmatkesh, Mona Haddad [1 ]
Abedi, Seyed Mohammad [2 ,3 ]
Hosseinimehr, Seyed Jalal [1 ]
机构
[1] Mazandaran Univ Med Sci, Dept Radiopharm, Fac Pharm, Sari, Iran
[2] Mazandaran Univ Med Sci, Dept Radiol, Fac Med, Sari, Iran
[3] Mazandaran Univ Med Sci, Cardiovasc Res Ctr, Sari, Iran
关键词
Tc-99m; EGFR; non-small-cell lung cancer; peptide; tumor targeting; GROWTH-FACTOR RECEPTOR; RADIOCHEMICAL INVESTIGATIONS; VITRO/IN VIVO; TYROSINE KINASE; RENAL UPTAKE; LIGAND; ACID; EGFR; OVEREXPRESSION; DIAGNOSIS;
D O I
10.2217/fon-2016-0426
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: In this study, radiolabeled D4 peptide conjugate was studied as a radiotracer for imaging of non-small-cell lung cancer with overexpression of EGFR. Methods: HYNIC-(Ser) 3-D4 peptide was labeled with Tc-99m using tricine as a co-ligand. Cellular specific binding and internalization as well as in vivo tumor targeting were assessed. Results: The in vitro experiments showed good cellular specific binding. Tumor uptake values as % ID/g were 7.55 and 6.82% at 1 and 4 h after injection, respectively. The presaturation of EGFR in xenografted nude mice reduced 36% tumor uptake of radioactivity at 1 h after injection that confirmed in vivo specificity. Conclusion: Findings showed this radiolabeled peptide is a promising candidate for tumor targeting and molecular imaging of non-small-cell lung cancer.
引用
收藏
页码:893 / 905
页数:13
相关论文
共 43 条
  • [1] Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
    Ahlgren, Sara
    Wallberg, Helena
    Tran, Thuy A.
    Widstrom, Charles
    Hjertman, Magnus
    Abrahmsen, Lars
    Berndorff, Dietmar
    Dinkelborg, Ludger M.
    Cyr, John E.
    Feldwisch, Joachim
    Orlova, Anna
    Tolmachev, Vladimir
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (05) : 781 - 789
  • [2] Pyrazolyl conjugates of bombesin:: a new tridentate ligand framework for the stabilization of fac-[M(CO)3]+ moiety
    Alves, Susana
    Correia, Joao D. G.
    Santos, Isabel
    Veerendra, Bhadrasetty
    Sieckman, Gary L.
    Hoffman, Timothy J.
    Rold, Tammy L.
    Figueroa, Said Daibes
    Retzloff, Lauren
    McCrate, Joseph
    Prasanphanich, Adam
    Smith, Charles J.
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (05) : 625 - 634
  • [3] Targeting tyrosine kinases in cancer: The second wave
    Baselga, Jose
    [J]. SCIENCE, 2006, 312 (5777) : 1175 - 1178
  • [4] Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations
    Behr, TM
    Goldenberg, DM
    Becker, W
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (02) : 201 - 212
  • [5] Berndorff D, 2006, J NUCL MED, V47, P1707
  • [6] Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer
    Brink, I
    Schumacher, T
    Mix, M
    Ruhland, S
    Stoelben, E
    Digel, W
    Henke, M
    Ghanem, N
    Moser, E
    Nitzsche, EU
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (12) : 1614 - 1620
  • [7] Imaging EGFR and HER2 by PET and SPECT: A Review
    Corcoran, Emily B.
    Hanson, Robert N.
    [J]. MEDICINAL RESEARCH REVIEWS, 2014, 34 (03) : 596 - 643
  • [8] Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours
    de Visser, M.
    Bernard, H. F.
    Erion, J. L.
    Schmidt, M. A.
    Srinivasan, A.
    Waser, B.
    Reubi, J. C.
    Krenning, E. P.
    de Jong, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (08) : 1228 - 1238
  • [9] 99m-technetium-labelled peptide-HYNIC conjugates: Effects of lipophilicity and stability on biodistribution
    Decristoforo, C
    Mather, SJ
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (04) : 389 - 396
  • [10] Decristoforo C, 2002, Q J NUCL MED, V46, P195